Antileukemia activity of MSFTZ–a novel flavanone analog
- 1 July 2006
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Anti-Cancer Drugs
- Vol. 17 (6), 641-647
- https://doi.org/10.1097/01.cad.0000215060.70566.59
Abstract
A newly synthesized flavanone derivative, (±)-(3aRS,4SR)-2-(2-chloro-4-methyl- sulfonylphenyl)-4′-chloro-3a,4-diethoxy-flavane[4,3-d]-Δ1,9b-1,2,3-thiadiazoline (MSFTZ), was investigated for its antileukemia activity and molecular mechanisms. Cytotoxicity assay confirmed the high antiproliferative efficiency of MSFTZ in six leukemia cell lines (including two drug-resistant cell lines), with 50% inhibition of cell viability values ranging from 1.0 to 9.2 μmol/l. The results of flow cytometry assay showed that the percentage of apoptotic HL-60 cells was 68.3% after 48 h treatment with MSFTZ, suggesting that the activation of the apoptosis pathway was an anticancer property of MSFTZ. Furthermore, the protein changes related to apoptosis were investigated. Exposure of HL-60 cells to MSFTZ induced pro-caspase-9 and pro-caspase-3 cleavage, X-linked inhibitor of apoptosis protein and Bcl-XL downregulation, and poly(ADP-ribose) polymerase degradation. Treatment of cells with MSFTZ resulted in a time-dependent reduction in phosphorylation (activation) of extracellular signal-regulated kinase 1/2 and an increase in phosphorylation (activation) of Jun N-terminal kinase. Taken together, our results demonstrated that activation of mitogen-activated protein kinase and apoptotic cascade is involved in MSFTZ-induced antileukemia activity. All data suggest that MSFTZ is a promising chemotherapy drug.Keywords
This publication has 31 references indexed in Scilit:
- Silibinin Efficacy against Human Hepatocellular CarcinomaClinical Cancer Research, 2005
- The role of p38 MAPK activation in auranofin‐induced apoptosis of human promyelocytic leukaemia HL‐60 cellsBritish Journal of Pharmacology, 2005
- Phase I and Pharmacologic Study of Infusional Topotecan and Carboplatin in Relapsed and Refractory Acute LeukemiaClinical Cancer Research, 2005
- Tirapazamine Cytotoxicity for Neuroblastoma Is p53 DependentClinical Cancer Research, 2005
- Cannabis-induced cytotoxicity in leukemic cell lines: the role of the cannabinoid receptors and the MAPK pathwayBlood, 2005
- Oral Silibinin Inhibits Lung Tumor Growth in Athymic Nude Mice and Forms a Novel Chemocombination with Doxorubicin Targeting Nuclear Factor κB–Mediated Inducible ChemoresistanceClinical Cancer Research, 2004
- Toxicity and Cell Cycle Effects of Synthetic 8-Prenylnaringenin and Derivatives in Human CellsPharmacology, 2004
- Hydroxylation at C4′ or C6 is essential for apoptosis-inducing activity of flavanone through activation of the caspase-3 cascade and production of reactive oxygen speciesFree Radical Biology & Medicine, 2004
- P-glycoprotein-mediated drug efflux is a resistance mechanism of chronic myelogenous leukemia cells to treatment with imatinib mesylateLeukemia, 2004
- Identification of the regulatory phosphorylation sites in pp42/mitogen-activated protein kinase (MAP kinase).The EMBO Journal, 1991